Wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Entresto BPI Quiz

Total questions: 20

Worksheet time: 12mins

Name
Class
Date
1.

Following oral administration, sacubitril-valsartan dissociates into sacubitril which is further metabolized into (a)   and valsartan?

2.

The color of Entresto 50mg tablet:

a)

Pale Yellow

b)

Light Pink

c)

Violet White

d)

White

3.

The color of Entresto 200mg tablet:

a)

Pale Yellow

b)

Light Pink

c)

Violet White

d)

Purple

4.

100mg Entresto is equivalent to:

a)

50 mg Sac and 50 mg Val

b)

46 mg Sac and 54 mg Val

c)

48.6 mg Sac and 51.4 mg Val

d)

47.7 mg Sac and 52.3 mg Val

5.

The recommended starting dose of Entresto is (a)   except in certain situations.

6.

What is the target dose of Entresto?

a)

50 mg BID

b)

100 mg BID

c)

200 mg OD

d)

200 mg BID

7.

Treatment of Entresto can be initiated in patients with serum potassium level <5.4 mmol/l?

a)

True

b)

False

8.

Treatment with Entresto can be initiated in the following except:

a)

SBP >= 100 mmHg

b)

Patients who stopped using ACEi for 36 hours

c)

Patients using direct renin inhibitor

d)

Patients with serum Potassium level of <5.4 mmol/l

9.

What is the considered Entresto starting dose for patients with SBP >= 100 mmHg to 110 mmHg?

a)

50 mg BID

b)

100 mg BID

c)

200 mg BID

d)

100 mg OD

e)

50 mg OD

10.

Should Entresto be initiated on patients with SBP <100 mmHg?

a)

Yes, but with caution.

b)

No.

c)

Yes, Use 50 mg OD

d)

It depends on the situation.

11.

What is the recommended dose for Entresto in patients with moderate renal impairment?

a)

50 mg OD

b)

50 mg BID

c)

100 mg BID

d)

100 mg OD

12.

What is the recommended dose for Entresto in patients with moderate hepatic impairment?

a)

No dose adjustment is required.

b)

100 mg OD

c)

50 mg BID

d)

100 mg BID

13.

Use of Entresto may be associated with decrease renal function.

a)

True

b)

False

c)

Sometimes

d)

Not really.

14.

Angioedema has been reported in patients treated with Entresto.

a)

No.

b)

Yes.

c)

Maybe.

d)

Never.

e)

I don't know.

15.

Caution should be exercised when initiating Entresto to NYHA IV patients due to limited clinical experience in this population.

a)

True.

b)

False.

16.

Co-administration with furosemide influenced the pharmacokinetics of Entresto.

a)

True.

b)

False.

17.

Entresto can be initiated during pregnancy. True or False.

(a)  

18.

A single dose of Entresto 1200 mg and multiple doses of 900 mg were studied in healthy volunteers and were not well tolerated. True or False.

(a)  

19.

Co-administration of Entresto with metformin both reduced the Cmax and AUC of metformin.

a)

True

b)

False

20.

Entresto inhibits or induces CYP450 enzymes.

a)

True

b)

False